Journal of Oral and Maxillofacial Surgery
Volume 67, Issue 5 , Pages 990-995 , May 2009

Randomized, Prospective Trial Comparing Bridging Therapy Using Low-Molecular-Weight Heparin With Maintenance of Oral Anticoagulation During Extraction of Teeth

  • Branislav V. Bajkin, MD

      Affiliations

    • Assistant and Oral Surgeon, Department of Oral Surgery, Dental Clinic of Vojvodina, Medical Faculty, University of Novi Sad, Novi Sad, Serbia
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Bajkin: Department of Oral Surgery, Dental Clinic of Vojvodina, Medical Faculty, University of Novi Sad, Hajduk Veljkova 12, 21000 Novi Sad, Serbia
  • ,
  • Stevan L. Popovic, PhD

      Affiliations

    • Professor and Hematologist, Director of the Clinic of Hematology, Clinical Center of Vojvodina, Novi Sad, Serbia
  • ,
  • Srecko D.J. Selakovic, PhD

      Affiliations

    • Professor and Oral Surgeon, Head of Department of Oral Surgery, Dental Clinic of Vojvodina, Medical Faculty, University of Novi Sad, Novi Sad, Serbia

References 

  1. Ward BW, Smith MH. Dentoalveolar procedures for the anticoagulated patient: Literature recommendations versus current practice. J Oral Maxillofac Surg. 2007;65:1454
  2. Mulligan R, Weitzel KG. Pretreatment management of the patients receiving anticoagulant drugs. J Am Dent Assoc. 1988;117:479
  3. Johnson WT, Leary JM. Management of dental patients with bleedng disorders: Review and update. Oral Surg Oral Med Oral Pathol. 1988;66:297
  4. Roser SM, Rosenbloom B. Continued anticoagulant in oral surgery procedures. Oral Surg Oral Med Oral Pathol. 1975;40:448
  5. Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med. 1998;158:1610
  6. Devani P, Lavery KM, Howell CJT. Dental extractions in patients on warfarin: Is alteration of anticoagulant regime necessary?. Br Dent J. 1998;36:107
  7. Blinder D, Manor Y, Martinowitz U, et al. Dental extractions in patients maintained on oral anticoagulant therapy: Comparison of INR value with occurrence of postoperative bleeding. Int J Oral Maxillofac Surg. 2001;30:518
  8. Evans IL, Sayers MS, Gibbons AJ, et al. Can warfarin be continued during dental extraction? (Results of a randomized controlled trial). Br J Oral Maxillofac Surg. 2002;40:248
  9. Sacco R, Sacco M, Carpenedo M, et al. Oral surgery in patients on oral anticoagulant therapy: A randomized comparison of different INR targets. J Thromb Haemost. 2006;4:688
  10. Al-Mubarak S, Rass MA, Alsuwyed A, et al. Thromboembolic risk and bleeding in patients maintaining or stopping oral anticoagulant therapy during dental extraction. J Thromb Haemost. 2006;4:689
  11. Salam S, Yusuf H, Milosevic A. Bleeding after dental extractions in patients taking warfarin. Br J Oral Maxillofac Surg. 2007;45:463
  12. Ferrieri GB, Castiglioni S, Carmagnola D, et al. Oral surgery in patients on anticoagulant treatment without therapy interruption. J Oral Maxillofac Surg. 2007;65:1149
  13. Aframian DJ, Lalla RV, Peterson DE. Management of dental patients taking common hemostasis-altering medications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:S45.e1
  14. Beirne OR. Evidence to continue oral anticoagulant therapy for ambulatory oral surgery. J Oral Maxillofac Surg. 2005;63:540
  15. Bodner L, Weinstein JM, Baumgarten AK. Efficacy of fibrin sealent in patients on various levels of oral anticoagulant undergoing oral surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:421
  16. Campbell JH, Alvarado F, Murray RA. Anticoagulation and minor oral surgery: Should the anticoagulation regimen be altered?. J Oral Maxillofac Surg. 2000;58:131
  17. Todd DW. Evidence to support an individualized approach to modification of oral anticoagulant therapy for ambulatory oral surgery. J Oral Maxillofac Surg. 2005;63:536
  18. Todd DW, Roman A. Outpatient use of low-molecular weight heparin in an anticoagulated patient requiring oral surgery: Case report. J Oral Maxillofac Surg. 2001;59:1090
  19. Johnson-Leong C, Rada RE. The use of low-molecular-weight heparins in outpatient oral surgery for patients receiving anticoagulation therapy. J Am Dent Assoc. 2002;133:1083
  20. Dejani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: Recommendations by the American Heart Association. J Am Dent Assoc. 1997;128:1142
  21. Yasaka M, Naritomi H, Minematsu K. Ischemic stroke associated with brief cessation of warfarin. Thromb Res. 2006;118:290
  22. Blinder D, Manor Y, Martinovitz U, et al. Dental extractions in patients maintained on continued oral anticoagulant: Comparison of local hemostatic modalities. Oral Surg Oral Med Oral Pathol. 1999;88:137
  23. Halfpenny W, Fraser JS, Adlam DM. Comparison of 2 haemostatic agents for the prevention of postextractional hemorrhage in patients on anticoagulants. Oral Surg Oral Med Oral Pathol. 2001;92:257
  24. Carter G, Goss A, Lloyd J, et al. Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: A randomized prospective clinical study. J Oral Maxillofac Surg. 2003;61:1432
  25. Sindet-Pedersen S, Ramstrom G, Bernvil S, et al. Haemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med. 1989;320:840
  26. Carter G, Goss A. Tranexamic acid mouthwash—A prospective randomized study of a 2-day regimen vs. 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg. 2003;32:504
  27. Mehra P, Cottrell DA, Bestgen SC, et al. Management of heparin therapy in the high-risk, chronically anticoagulated, oral surgery patient: A review and proposed nomogram. J Oral Maxillofac Surg. 2000;58:198
  28. Scully C, Wolff A. Oral surgery in patients on anticoagulant therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:57
  29. Little JW, Miller CS, Henry RG, et al. Antithrombotic agents: Implication in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:544
  30. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular weight heparin thromboprophylaxis. Blood. 2005;106:2710
  31. Morris TA, Castrejon S, Devendra G, et al. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin. Chest. 2007;132:1131
  32. Beirne OR. Discussion: Outpatient use of low-molecular weight heparin in an anticoagulated patient requiring oral surgery: Case report. J Oral Maxillofac Surg. 2001;59:1092
  33. Lev-Ran O, Kramer A, Gurevitch J, et al. Low-molecular-weight heparin for prosthetic heart valves: Treatment failures. Ann Thorac Surg. 2000;69:264
  34. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest. 2001;119(Suppl):22S
  35. Jaffer AK, Ahmed M, Brotman DJ, et al. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: A standardized bridging therapy protocol. J Thromb Thrombolys. 2005;20:11
  36. Spyropoulos AC, Bauersachs RM, Omran H, et al. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin. 2006;22:1109
  37. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation. 2004;110:1658
  38. Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight-heparin as bridging anticoagulation during interruption of warfarin: Assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med. 2004;164:1319
  39. Spyropoulos AC, Turpie AG, Dunn AS, et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: The REGIMEN Registry. J Thromb Haemost. 2006;4:1246
  40. Fanikos J, Tsilimingras K, Kucher N, et al. Comparison of efficacy, safety, and cost of low-molecular weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol. 2004;93:247
  41. Lowry JC. Thromboembolic disease and thromboprophylaxis in oral and maxillofacial surgery: Experience and practice. Br J Oral Maxillofac Surg. 1995;33:101

 This work was performed at the Department of Oral Surgery, Dental Clinic of Vojvodina, Novi Sad, Serbia.

PII: S0278-2391(09)00035-4

doi: 10.1016/j.joms.2008.12.027

Journal of Oral and Maxillofacial Surgery
Volume 67, Issue 5 , Pages 990-995 , May 2009